Triple-negative breast cancer (TNBC) represents a highly aggressive and heterogeneous subtype of breast cancer (BC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PgR), and HER2 expression [1,2]. This evidence concerns the gene PGR and breast carcinoma.